Abstract
A multidrug-resistant variant of the human breast cancer cell line MCF-7 exhibits multiple biochemical changes including reduced estrogen receptor and increased EGF receptor levels, overexpression of the putative drug efflux pump and cross-resistance to carcinogens, estrogens and antiestrogens. Philip Vickers and colleagues consider the usefulness of this model to the study of clinical transition of breast cancer to a hormonally unresponsive, highly malignant state.
Original language | English (US) |
---|---|
Pages (from-to) | 443-445 |
Number of pages | 3 |
Journal | Trends in Pharmacological Sciences |
Volume | 9 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1988 |
Externally published | Yes |
ASJC Scopus subject areas
- Toxicology
- Pharmacology